CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-14 | Beyer Russell P Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2022-09-13 | Beyer Russell P CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +274,875 | 274,875 | ||
| 2022-03-16 | Beyer Russell P Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2021-11-17 | Beyer Russell P Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2021-10-26 | Beyer Russell P Chief Financial Officer | Sale | −278 | $7.90 | $2K | 0 |
| 2021-10-25 | Beyer Russell P Chief Financial Officer | Grant or award | +129 | $7.78 | $1K | 278 |
| 2021-10-18 | Beyer Russell P Chief Financial Officer | Grant or award | +2,475 | $10.10 | $25K | 2,475 |
| 2021-09-29 | Beyer Russell P Chief Financial Officer | Grant or award | +10 | $10.08 | $101 | 15 |
| 2021-09-28 | Beyer Russell P Chief Financial Officer | Grant or award | +149 | $10.08 | $2K | 149 |
| 2021-09-28 | Beyer Russell P Chief Financial Officer | Grant or award | +5 | $10.07 | $50 | 5 |
Page 1 of 1 · 10 trades